Pharmaceutical and Cosmetic System Law
Shahriar eslamitabar
Articles in Press, Accepted Manuscript, Available Online from 18 February 2025
Abstract
Background and Objective: economic access to medicine and treatment is one of the most important dimensions of the right to health, which is considered one of the goals of national development in addition to international human rights. Achieving this important goal is possible by using correct and specific ...
Read More
Background and Objective: economic access to medicine and treatment is one of the most important dimensions of the right to health, which is considered one of the goals of national development in addition to international human rights. Achieving this important goal is possible by using correct and specific strategies such as pricing and compensation of costs through insurance.Methods: First, the literature of the article was reviewed using e-books, and articles, then the qualitative data was analyzed through content analysis and a practical model was presented.Results: Price control is done in two ways, direct and indirect. Determining the price and correcting it, it is the direct type, and compensation of costs through insurance is considered the indirect type. As the first control step, pricing strategies are followed based on two basic principles: 1- Value-based pricing, which is related to drug effects and drug cost, and includes the same requirements. 2- Price Classification based on the type and nature of the drug, including generic, under patent and imported.Conclusion: Since Iran has recently abandoned the Cost Plus method (determining the prices based on a percentage more than the total cost), it is necessary to constantly regulated the prices according to the current conditions, needs and the existence of similar drugs, but This action dose not seems correct in any situation and the necessary considerations regarding single-prescription drugs have not been taken into account. While advanced countries such as France and England include all drugs in the insurance coverage list based on their medicinal nature without special requirements and prerequisites, the budget of countries such as Iran does not allow such a thing.
Pharmaceutical and Cosmetic System Law
آسیه خلیفه زاده
Articles in Press, Accepted Manuscript, Available Online from 19 January 2025
Abstract
This article examines the state of pharmaceutical regulations in the developing world by constructing international indices derived from World Health Organization data. The past two decades have been marked by profound changes in the pharmaceutical sector, including a complete overhaul of intellectual ...
Read More
This article examines the state of pharmaceutical regulations in the developing world by constructing international indices derived from World Health Organization data. The past two decades have been marked by profound changes in the pharmaceutical sector, including a complete overhaul of intellectual property systems at the behest of the World Trade Organization and the consolidation of global active pharmaceutical ingredient suppliers in China and India. Although drug ownership laws have been regulated and implemented globally, we surprisingly have little information about how national market entry standards and the regulation of pharmaceutical products have changed.
Pharmaceutical and Cosmetic System Law
Abbas Kobariaizadeh; Roya Ayazi-Nasrabadi
Volume 1, Issue 2 , December 2025, , Pages 161-174
Abstract
Background and Aims: Nowadays, corruption, especially in public sectors, has become the main concern of governments, and in addition to being a domestic and national issue at the international level, it is also an important goal to deal with it for the benefit of customers or consumers. methods: ...
Read More
Background and Aims: Nowadays, corruption, especially in public sectors, has become the main concern of governments, and in addition to being a domestic and national issue at the international level, it is also an important goal to deal with it for the benefit of customers or consumers. methods: This article was written using Paper and Ebooks and articles available in real and virtual libraries in a descriptive-explanatory way.Results: Effective and efficient governance is the main and integral part for the health of all government departments. Corruption and transparency are two sides of the same coin, so that the increase of one of them causes the decrease of the other. Therefore, governments seek to improve health and fight corruption by resorting to domestic and international legal solutions, including promoting transparency as one of the main criteria of good governance.Conclusion: In order to reduce corruption and improve health in all service and production sectors, transparency should be increased; And for this purpose, while approving the appropriate laws and regulations, it is necessary to carry out legal control and supervision in various forms seriously and continuously. In the fight against fraud and smuggling, common solutions are usually followed, because these two phenomena are related to each other; It means that contraband goods are mostly fake. The use of barcode identification and tracking, continuous inspection, proper regulation before and after entering the market of products and goods are among the most important of these solutions.
Pharmaceutical and Cosmetic System Law
Abbas Kebriaeezadeh; Vahideh Montazeri; Roya Ayazi-Nasrabadi
Abstract
Background and Objective: According to the principles of the right to health, easy and timely access to quality medicines is one of the fundamental and essential rights of all human beings. Therefore, these medicines should be made available to people in need at the right time and in sufficient quantities.Methods: ...
Read More
Background and Objective: According to the principles of the right to health, easy and timely access to quality medicines is one of the fundamental and essential rights of all human beings. Therefore, these medicines should be made available to people in need at the right time and in sufficient quantities.Methods: This article was prepared using the documents and criteria available in the Food and Drug Organization of Iran and the World Health Organization (WHO), and it was expressed analytically by comparing and contrasting them.Findings: From the perspective of the World Health Organization, access to essential medicines as a minimum right is considered one of the core indicators of the right to health. This issue has been considered by some countries, especially poor and less developed countries, based on its affordability. Due to the vital importance of these medicines, the World Health Organization publishes a list of essential medicines every year, taking into account the minimum needs, on a biennial basis.Conclusion: Although the Islamic Republic of Iran has taken substantial measures to meet the pharmaceutical needs of its citizens through legal supervision of drug prices and markets, especially drug imports, and the implementation of the generic plan, no serious work has been done to prepare a list of essential medicines. However, given the progress in this field and the country's relative self-sufficiency, it does not seem necessary to prepare a domestic list in line with the World Health Organization's list of essential medicines. Each country compiles its own independent list of essential medicines based on its production capacity and needs. Accordingly, governments should prepare and supply (produce or import) the list of essential medicines based on the World Health Organization list, climatic conditions, production capacity, and domestic to ensure equitable access to essential drugs is provided to all segments of society.
